Oncology Precision Medicine Market To Register Unwavering Growth By 2027

1. Global Oncology Precision Medicine Market Overview, Experiments, Evolution, Key Players And Forecast Until 2027 Oncology precision medicine refers to the approach being employed for improved patient care that enables healthcare experts to select oncology treatments that are expected to help patients based on genetic understanding of cancers. Rising cancer prevalence, rising usage of predictive biomarker for effective diagnosis, declining cost of genomic sequencing, and rapid technological advancements are some key market dynamic factors. In addition, reduction in error and trial-based drug prescription through the use of pharmacogenomics is also expected to fuel market growth. Competitive Landscape: Key players in global oncology precision medicine market include: Abbott Laboratories, Agilent Technologies, Inc., Almac Group Ltd., ANGLE plc., ASURAGEN INC., BGI Group, BioMérieux S.A., Bio-Rad Laboratories, Inc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd., Gilead Sciences, Inc., Illumina, Inc., Konica Minolta, Inc., Laboratory Corporation of America Holdings, MDx Health, Inc., Myriad Genetics, Inc., Novartis AG, OPKO Health, Inc., Pacific Biosciences of California, Inc., Quest Diagnostics, QIAGEN N.V., Thermo Fisher Scientific Inc., and among others. Get Free PDF Brochure of this Report @https://www.fostermarketresearch.com/product/industry/10/505/Pdf%20 Brochure/ The market players have primarily adopted acquisition and getting Food and Drugs Administration (FDA) approval as strategies to strengthen their position in the global market. For instance, in June 2020, Predictive Oncology Inc. has acquired BioDtech, Inc. and Soluble Therapeutics, Inc. for an undisclosed amount. This acquisition has strengthened the oncology precision medicine development capabilities of the Predictive Oncology Inc. Additionally, in January 2019, Eli Lilly and Co. has acquired Loxo Oncology Inc. for approximately $8 billion and this acquisition has further solidified the market position of the Eli Lilly while enabling it to boost its precision medicine portfolio for oncology drugs. In addition to this, in January 2020, Blueprint Medicines has received the U.S. FDA approval for its Ayvakit (avapritinib) that is used as a precision therapy for unresectable or metastatic gastrointestinal stromal tumors (GIST). These developments have enabled companies to strengthen their product portfolio and expand their geographical presence across different countries and regions. Market Taxonomy:

2. By Ecosystem Applied Sciences ○ Genomics ○ Pharmacogenomics ○ Other Applied Sciences Precision Diagnostics ○ Molecular Diagnostics (MDx) ○ Medical Imaging Digital Health and Information Technology ○ Clinical Decision Support Systems (CDSS) ○ Big Data Analytics ○ IT Infrastructure ○ Genomics Informatics ○ In-Silico Informatics ○ Mobile Health Precision Therapeutics ○ Clinical Trials ○ Cell Therapy ○ Drug Discovery and Research ○ Gene Therapy ● ● ● ● By Application Breast Cancer Lung Cancer Colorectal Cancer Prostate Cancer Cervical Cancer Ovarian Cancer Other Cancers ● ● ● ● ● ● ● For More Information of This Report @https://www.fostermarketresearch.com/product/industry/10/505/ Market Dynamics: Notable initiatives undertaken by the companies to accelerate oncology precision medicine research and development drives global market growth. For instance, according to the HealthITAnalytics October 2019 publication, the computer scientists from Microsoft Corporation are partnering with researchers at the Jackson Laboratory in order to boost development of artificial intelligence (AI) technology for cancer treatment, enhancing the process of precision medicine development while improving upon patient care. The laboratory has developed a tool referred to as the Clinical Knowledge (CKB), which is a searchable database and medical experts can store, sort

3. and interpret complex genomic data to share crucial information regarding effective treatment options and related clinical trials. Such initiatives are expected to contribute to market growth. However, the lack of awareness, education, and expertise for oncology precision medicine implementation and inadequate reimbursement scenario for oncology precision medicine are certain major market growth restraining factors. FAQ's: Note: This report provides in-depth analysis of the global oncology precision medicine market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2021-2027), considering 2019, as the base year. What are the trends adopted by key players in the global oncology precision medicine market? What key factors are expected to increase the demand for oncology precision medicine market during the forecast period 2021-2027? What is the short-term, mid-term, and long-term impact of COVID-19 on oncology precision medicine market? What are the major challenges inhibiting the growth of the global oncology precision medicine market? What is the total market value (US$ Mn) generated in global oncology precision medicine market by ecosystem in 2019 and what are the forecasts by 2027? Which application is expected to dominate the oncology precision medicine market in the coming years? What was the total revenue generated by the global oncology precision medicine market across different regions (North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa) in 2019, along with CAGR (%) for the period (2021-2027)? Who are the key players contributing to the growth of the global oncology precision medicine market, and what are the new strategies adopted by them to retain a market share in the industry? ● ● ● ● ● ● ● ● Buy Now This Business Strategic Report to Improve Your Profits @ https://www.fostermarketresearch.com/product/buy/10/505/ About Foster Market Research: Foster Market Research is a global market intelligence and advisory firm engaged in providing data-driven research extract from rigorous analysis, to the clients to make critical business decisions and execute them successfully. Foster connects over various distribution channels and numerous markets for great understanding of the trends and market to deliver our clients with accurate data. Our focus is on providing market research that delivers a positive impact on your business. We work continuously to provide our clients with the most accurate analytics

4. data and research reports without any delay so as to improve their business strategies and provide them with rich customer experience. Contact Us: 1701 Royal Lane, #1306, Dallas Tx-75229 Phone: +1 469 4981929 Email: support@fostermarketresearch.com